- Home
- PNI vs HBIO Comparison
PNI vs HBIO Comparison
Compare PNI & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNI
- HBIO
- Stock Information
- Founded
- PNI 2002
- HBIO 1901
- Country
- PNI United States
- HBIO United States
- Employees
- PNI N/A
- HBIO N/A
- Industry
- PNI Trusts Except Educational Religious and Charitable
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- PNI Finance
- HBIO Industrials
- Exchange
- PNI Nasdaq
- HBIO Nasdaq
- Market Cap
- PNI 79.0M
- HBIO 93.8M
- IPO Year
- PNI N/A
- HBIO 2000
- Fundamental
- Price
- PNI $7.15
- HBIO $1.93
- Analyst Decision
- PNI
- HBIO
- Analyst Count
- PNI 0
- HBIO 0
- Target Price
- PNI N/A
- HBIO N/A
- AVG Volume (30 Days)
- PNI 26.4K
- HBIO 248.4K
- Earning Date
- PNI 01-01-0001
- HBIO 03-06-2025
- Dividend Yield
- PNI 4.76%
- HBIO N/A
- EPS Growth
- PNI N/A
- HBIO N/A
- EPS
- PNI N/A
- HBIO N/A
- Revenue
- PNI N/A
- HBIO $97,732,000.00
- Revenue This Year
- PNI N/A
- HBIO N/A
- Revenue Next Year
- PNI N/A
- HBIO $4.32
- P/E Ratio
- PNI N/A
- HBIO N/A
- Revenue Growth
- PNI N/A
- HBIO N/A
- 52 Week Low
- PNI $6.03
- HBIO $1.81
- 52 Week High
- PNI $7.89
- HBIO $4.93
- Technical
- Relative Strength Index (RSI)
- PNI 43.59
- HBIO 40.61
- Support Level
- PNI $6.96
- HBIO $1.81
- Resistance Level
- PNI $7.27
- HBIO $2.07
- Average True Range (ATR)
- PNI 0.06
- HBIO 0.13
- MACD
- PNI 0.00
- HBIO -0.01
- Stochastic Oscillator
- PNI 61.29
- HBIO 25.53
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.